Results 281 to 290 of about 2,311,673 (316)
Thrombolytic Therapy for Massive Pulmonary Embolism in an Antiphospholipid Syndrome Patient With Severe Thrombocytopenia: A Case Report. [PDF]
Clin Case RepAhmadzadeh A +5 more
europepmc +1 more source
IgM Antiphospholipid Antibodies in Antiphospholipid Syndrome: Prevalence, Clinical Associations, and Diagnostic Implications-A Scoping Review. [PDF]
J Clin MedOčková M +5 more
europepmc +1 more source
Erratum: Diagnosis and management of antiphospholipid syndrome [Erratum]. [PDF]
Aust Prescreuropepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Nature Reviews Disease Primers, 2018
This corrects the article DOI: 10.1038/nrdp.2017.103.
K. Schreiber +9 more
semanticscholar +7 more sources
This corrects the article DOI: 10.1038/nrdp.2017.103.
K. Schreiber +9 more
semanticscholar +7 more sources
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria
Arthritis & Rheumatology, 2023To develop new antiphospholipid syndrome (APS) classification criteria with high specificity for use in observational studies and trials, jointly supported by the American College of Rheumatology (ACR) and EULAR.
M. Barbhaiya +64 more
semanticscholar +1 more source
Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management
British medical journal, 2023Antiphospholipid syndrome (APS) is a thrombo-inflammatory disease propelled by circulating autoantibodies that recognize cell surface phospholipids and phospholipid binding proteins.
J. Knight, D. Branch, T. Ortel
semanticscholar +1 more source
Clinical and Experimental Medicine, 2003
The antiphospholipid syndrome (APS) was reported in the early 1980s as the association of thrombosis, recurrent pregnancy loss in the presence of anticardiolipin antibodies (aCL) and/or lupus anticoagulant (LA). Since then, many other clinical manifestations have been associated with aPL.
M J, Cuadrado, C, Lopez-Pedrera
+7 more sources
The antiphospholipid syndrome (APS) was reported in the early 1980s as the association of thrombosis, recurrent pregnancy loss in the presence of anticardiolipin antibodies (aCL) and/or lupus anticoagulant (LA). Since then, many other clinical manifestations have been associated with aPL.
M J, Cuadrado, C, Lopez-Pedrera
+7 more sources
Antiphospholipid syndrome, antiphospholipid antibodies, and stroke
International Journal of Stroke, 2022Antiphospholipid syndrome (APS) is a prothrombotic autoimmune disease with heterogeneous clinicopathological manifestations and is a well-established cause of acute ischemic stroke (AIS) and transient ischemic attack (TIA), particularly in younger ...
Prabal Mittal +5 more
semanticscholar +1 more source
Pediatric Clinics of North America, 2005
Antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterized by a combination of arterial or venous thrombosis and recurrent fetal loss, accompanied by elevated titers of antiphospholipid antibodies (aPL). APS has been recognized as the leading cause of vascular thrombosis in children.
RAVELLI, ANGELO, MARTINI, ALBERTO
openaire +3 more sources
Antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterized by a combination of arterial or venous thrombosis and recurrent fetal loss, accompanied by elevated titers of antiphospholipid antibodies (aPL). APS has been recognized as the leading cause of vascular thrombosis in children.
RAVELLI, ANGELO, MARTINI, ALBERTO
openaire +3 more sources
The Lancet, 2010
The antiphospholipid syndrome causes venous, arterial, and small-vessel thrombosis; pregnancy loss; and preterm delivery for patients with severe pre-eclampsia or placental insufficiency. Other clinical manifestations are cardiac valvular disease, renal thrombotic microangiopathy, thrombocytopenia, haemolytic anaemia, and cognitive impairment ...
Ruiz-Irastorza, Guillermo +3 more
openaire +5 more sources
The antiphospholipid syndrome causes venous, arterial, and small-vessel thrombosis; pregnancy loss; and preterm delivery for patients with severe pre-eclampsia or placental insufficiency. Other clinical manifestations are cardiac valvular disease, renal thrombotic microangiopathy, thrombocytopenia, haemolytic anaemia, and cognitive impairment ...
Ruiz-Irastorza, Guillermo +3 more
openaire +5 more sources